Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $3.39 USD
Change Today +0.10 / 3.04%
Volume 161.9K
ICAD On Other Exchanges
As of 8:10 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

icad inc (ICAD) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/3/14 - $11.63
52 Week Low
06/30/15 - $3.22
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ICAD INC (ICAD)

icad inc (ICAD) Related Bloomberg News

View More Bloomberg News

icad inc (ICAD) Related Businessweek News

No Related Businessweek News Found

icad inc (ICAD) Details

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer in the United States and internationally. It operates through two segments, Cancer Detection and Cancer Therapy. The company provides electronic brachytherapy (eBX) products, including Axxent eBx systems for the treatment of early stage breast cancer, endometrial cancer, and skin cancer, as well as for the treatment of other cancers or conditions where radiation therapy is indicated comprising intraoperative radiation therapy. It also offers digital mammography computer-aided detection (CAD) products, such as advanced image analysis and workflow solutions in breast imaging, which include SecondLook digital CAD systems that detects and identifies suspicious masses and micro-calcifications; and PowerLook Advanced Mammography Platform, a computer server residing on a customer’s network that receives patient studies from the imaging modality, performs CAD analysis, and sends the CAD results to picture archiving and communication system and/or review workstations. In addition, the company’s digital mammography CAD products comprise magnetic resonance imaging applications, a tool to detect breast and prostate cancer; breast tomosynthesis systems; and advanced image analysis and workflow solutions in computed tomography (CT) colonography, including VeraLook that supports the detection of colonic polyps in conjunction with CT colonography. It serves hospitals, ambulatory care centers and free standing radiation oncology facilities, and other office-based uses. The company sells its products through sales organizations, as well as through various original equipment manufacturer partners, distributors, and resellers. It has a strategic partnership agreement with Invivo Corp. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was founded in 1984 and is headquartered in Nashua, New Hampshire.

141 Employees
Last Reported Date: 03/13/15
Founded in 1984

icad inc (ICAD) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $435.0K
President, Chief Financial Officer, Chief Ope...
Total Annual Compensation: $310.0K
Senior Vice President of Research & Developme...
Total Annual Compensation: $255.0K
Senior Vice President of Marketing & Strategy
Total Annual Compensation: $270.0K
Compensation as of Fiscal Year 2014.

icad inc (ICAD) Key Developments

iCAD, Inc. Announces Commercial Availability of Cervical Applicator for Treatment of Gynecological Cancers

iCAD, Inc. announced the commercial availability of a new cervical applicator for the Xoft Axxent Electronic Brachytherapy System. The applicator and multi-platform controller will be showcased in the iCAD/Xoft booth (#1239) at the American Association of Physicists in Medicine (AAPM) annual meeting from July 12-16, 2015 in Anaheim, CA. Data from several studies involving use of surface HDR electronic brachytherapy is also being presented in multiple poster and oral presentations throughout the meeting. The cervical applicator, Xoft's first multi-channel applicator, is used to deliver a precise dose of radiation to larger target areas of the cervix while minimizing exposure to healthy tissue. The addition of the cervical applicator completes Xoft's gynecological product line, allowing radiation oncologists to treat all gynecological indications with the Xoft System.

iCAD Announces Launch of iReveal® Breast Density Analysis Solution as Latest Addition to PowerLook Advanced Mammography Platform

iCAD, Inc. announced the launch of the iReveal® breast density module as the latest addition to the Company's PowerLook Advanced Mammography Platform (AMP)®. The iReveal software is designed to deliver automated, rapid and reproducible assessments of breast density to help identify patients that may experience reduced sensitivity to digital mammography due to dense breast tissue. iReveal uses an advanced software program to assess breast density based on the range of categories established by the American College of Radiology's Breast Imaging Reporting and Data System (BI-RADS®), automating the same analytical approach used by many experienced radiologists. In many cases, patients with dense breast tissue may be recommended for additional screening exams including use of breast tomosynthesis.

iCAD, Inc. Withdraws 2015 Financial Guidance Due to General Reimbursement Uncertainty

iCAD, Inc. announced that it is withdrawing its full year 2015 financial guidance due to general uncertainty related to reimbursement for non-melanoma skin cancer in the United States. The company's guidance was based on the assumption that there would be no changes to the reimbursement environment for fiscal 2015. The company is proactively working to gain clarity on the issue and will provide an update on reimbursement when appropriate.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICAD:US $3.39 USD +0.10

ICAD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Elekta AB kr57.80 SEK -0.40
Hologic Inc $38.03 USD +0.49
Merge Healthcare Inc $5.46 USD -0.03
View Industry Companies

Industry Analysis


Industry Average

Valuation ICAD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.1x
Price/Book 0.8x
Price/Cash Flow 33.8x
TEV/Sales 0.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ICAD INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at